Home/Entera Bio/Dr. William Levine
DW

Dr. William Levine

Chief Scientific Officer

Entera Bio

Entera Bio Pipeline

DrugIndicationPhase
EB613Osteoporosis (postmenopausal women)Phase 3
EB612HypoparathyroidismPhase 2
EBP05OsteoporosisPreclinical